Related Experiment Videos
WITHDRAWN: Dietary regulation for 'gestational diabetes'
1Liverpool Women's Hospital NHS Trust, Fetal Centre, Crown Street, Liverpool, UK, L8 7SS. steve.walkinshaw@lwh-tr.nwest.nhs.uk
The Cochrane Database of Systematic Reviews
|July 20, 2007
Summary
Primary dietary therapy for gestational diabetes shows no significant impact on birth weight or C-section rates. More research is needed to evaluate its effectiveness for impaired glucose metabolism during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Impaired glucose metabolism in pregnancy, including gestational diabetes, is linked to adverse pregnancy outcomes.
- Primary dietary therapy is a common management approach for diabetes during pregnancy.
Purpose of the Study:
- To evaluate the impact of primary dietary therapy on fetal growth and neonatal outcomes in women with gestational diabetes.
Main Methods:
- Systematic review of randomized controlled trials from the Cochrane Pregnancy and Childbirth Group trials register.
- Included trials compared primary dietary therapy with no specific treatment in pregnant women with abnormal glucose tolerance tests.
- Trial quality was assessed.
Main Results:
- Four studies with 612 women were analyzed; trials were small and of variable quality.
- No statistically significant differences were found in rates of macrosomia (birthweight > 4000g) between dietary therapy and no specific treatment groups.
- Cesarean delivery rates also showed no significant difference between the groups.
Conclusions:
- Current evidence is insufficient to determine the effectiveness of primary dietary therapy for managing impaired glucose metabolism in pregnancy.
- Further high-quality research is required to establish the role of dietary interventions in gestational diabetes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...